Articles On Althea Group Holdings (ASX:AGH)

Cannabis-based medicine supplier Althea (AGH) launches two new products to meet patient needsAlthea CBD25 is the company’s exclusive range of soft gel capsules which contain less than 25mg of cannabidiol and less than 0.25mg of THCSubject t...

Cannabis-based medicine supplier Althea Group (AGH) records growth across most key metrics in its two arms of business for the 2022 financial yearThe company grew its revenue by 77.8 per cent to $20.52 million and improved its cash outflows...

Benchmark sags as Materials sector delivers even more tedious disappointment Coal miners hand back yesterday’s gains as investors tire of Chinese whispers Cannabis offers relief for investors and health stocks climb as well. The ASX has e...

ECS is selling its medicinal cannabis farm in Tasmania Crypto ATMs are now a thing in weed dispensaries in the US Zelira Therapeutics nabs regulatory approval in Germany for insomnia medication Ever fancied your own cannabis farm? Well, t...

The Althea Group Holdings Ltd (ASX: AGH) share price is up 5.25% today and up 21.25% over the past four days, as the nano-cap grabs the attention of ASX investors again. Althea is an ASX cannabis share. The company is focused on the manuf...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a sizeable decline. At the time of writing, the benchmark index is down 0.95% to 6,614.3 points. Four shares that are not letting that hold them b...

Cannabis company Althea Group (AGH) achieves a record quarter with $6.5 million in receipts for customers, a 130 per cent increase from the previous corresponding period This means that over FY22, AGH tabled $22 million in receipts from cu...

Over the past decade, opioid-induced deaths were more likely to be due to prescription drugs than illegal drugs As scientists discover new ways to use the plant’s medicinal compounds, cannabis is seen as a possible solution to the opioid c...

The Health Products Regulatory Authority approves Althea’s (AGH) CBD12:THC10 product to be used as prescription and supply in Ireland The approval marks Althea’s entry into the Irish medicinal cannabis market, and the first stop of its pla...

The Market Herald brings together several cannabis industry insiders to discuss the market Industry experts discuss the changing nature of the regulatory framework in various jurisdictions, and the growing science-based sophistication of c...

Althea Group (AGH) sees its best first-half result to date with $9.4 million in revenue reported, an 84 per cent increase compared to this time last year The medicinal cannabis company saw cash receipts total $9.9 million, a 67 per cent in...

At the time of writing, the ASX 200 Health Index (XHJ) is down by 1.10%, while the benchmark ASX 200 has fallen by 2.15%. It’s all about earnings today for ASX health stocks. Here’s a highlight of where they stand in the first half.   Round...

Althea Group’s (AGH) German sales and distribution partner Nimbus Health is set to be acquired by global pharmaceutical company Dr Reddy’s Laboratories The NYSE-listed company says it will build on Nimbus Health’s strengths and introduce m...

Medical imaging software Resonance Health (ASX:RHT) has received the green light in the US for its LiverSmart medical device, making it eligible for recognition by the US government agencies and private insurers. Resonance received confirma...

Key points Althea delivered a record performance during the second quarter Strong demand for pharmaceutical cannabis helped drive its growth Althea is still burning through its cash despite its sales growth The Althea Group Holdings Ltd...

ASX cannabis shares were nothing short of a mixed bag last month. Several names did well but a large body of shares missed the benchmark completely. For some context, the S&P/ASX 200 Health Care index (ASX: XHJ) regained steam over th...

ASX cannabis shares were once one of the hottest sectors with no shortage of new pot stocks hitting the market. The Cann Group Ltd (ASX: CAN) share price, for example, skyrocketed almost 300% between September 2017 and January 2018 amid t...

Althea Group (AGH) hit a new high of $4.5 million in customer receipts over the recently completed September quarter The cannabis products producer explains receipts increased 116 per cent year on year and 57 per cent when compared to the...

Wall Street extends rebound US stocks mainly rose on Monday, in a continuation of the upward momentum at the end of last week. The S&P 500 index rose by 0.34% while the Nasdaq was up 0.84%, but the Dow Jones fell slightly (by 0.1%). Dat...

Last week California Governor Gavin Newsom signed Assembly Bill (AB-45), formally permitting the sales of hemp-derived CBD products in the state. Hemp has been legalised at the US federal level since 2018, but state agencies have been slow...

The growth of the global cannabis market and its associated products has been nothing short of phenomenal over the past five years, and Althea Group Holdings (AGH) says cannabis-infused drinks are next on the menu Landmark legislative chan...

The Little Green Pharma Ltd (ASX: LGP) share price has had a tough run over the past few months. This comes despite the medicinal cannabis producer releasing some positive announcements to the market of late. At Friday’s closing bell, Litt...

The Boston Beer Company (NYSE:SAM) is set to launch a new range of non-alcoholic cannabis-infused drinks in Canada with the help of Australian listed Althea Group Holdings’ (ASX:AGH) subsidiary. Peak processing Solutions will research and d...

Highlights EBOS (ASX:EBO) acquires Sentry Medical to expand into medical consumables Piedmont (ASX:PLL) completes initial investment in IronRidge Knosys (ASX:KNO) completes acquisition of LIBERO The S&P/ASX200 closed lower We...

Local stocks struggled for traction in Wednesday trade, as the major indexes drifted sideways following a weak lead out of the US. Banks and energy stocks were up, offsetting falls in resources and consumer staples. There were few major cat...

Highlights Biotechnology firm Mesoblast extended its loss on disappointing earnings and dropped 5%. Graphite producer Volt Resources dropped despite successfully raising capital via share placement. Medical data and technology firm He...

Highlights The ASX 200 declined as much as 1% by lunchtime as investors awaited June quarter GDP figures. Australia’s Q2 GDP rose 0.7% in the June quarter. Barring energy, all indices were trading in the red, while healthcare declined...

The Althea Group Holdings Ltd (ASX: AGH) share price is soaring today following news the company will soon be producing cannabis-infused drinks. A subsidiary of Althea has entered into agreements with Boston Beer Company Inc (NYSE: SAM) to...

Historic American brewery The Boston Beer Company (BCC) has tapped an Australian cannabis manufacturer to launch a new range of non-alcoholic cannabis-infused beverages in Canada. Under the deal, a subsidiary of Melbourne-based Althea Grou...

The Althea Group Holdings Ltd (ASX: AGH) share price has returned to trading today only to get smoked by investors. The cannabis company provided an update to market on its latest capital raising efforts. At the time of writing, Althea sha...

The ASX 200 health stocks index (XHJ) rose by 0.60% this morning, compared to the broader index which climbed by 0.40% Biopharmaceutical company Dimerix (ASX:DXB) announced that it has commenced ACTION3, a Phase III study in patients with f...

It was another positive close for the Australian bourse today with energy the standout sector. The ASX 200 closed 0.17% higher at 7,503 points while the ASX Emerging Companies Index gained 1.1% to close at 2,262 points. Leading the charge w...

Highlights Actinogen Medical has completed the global grant process for Xanamem with the official notification for the grant of its patent application in Brazil. Althea’s Canadian subsidiary, Peak Processing Solutions, has entered into...

In early afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to end the week deep in the red. At the time of writing, the benchmark index is down 1.5% to 7,228.6 points. Four ASX shares that are not letting that hold them ba...

The Althea Group Holdings Ltd (ASX: AGH) share price is on course to end the week on a positive note. In morning trade, the cannabis company’s shares are up 4% to 36.5 cents. Why is the Althea share price climbing? Investors have been bidd...

The 2021 financial year was overall a very good one for ASX shares. The S&P/ASX 200 Index (ASX: XJO) managed to put on a performance of 24% for the 12 months to 30 June 2021. That makes FY2021 one of the best financial years ever for t...

The Bod Australia Ltd (ASX: BDA) share price is a strong performer today following the release of a sales update. At the time of writing, shares in the CBD and hemp healthcare products company are up 3% to 35 cents. What’s driving the Bod...

Connecticut has become the latest US state to legalise recreational use of marijuana. The state’s governor has just signed a bill to allow people aged 21 and older to possess and consume marijuana, making it the 19th US state to do so. Here...

Summary Afterpay jumps on plans to expand reach with U.S. merchants Althea enters South African cannabis market worth US$667 million Bluechiip shares close strong on a settlement agreement with Labcon North America The S&P/ASX...

On Thursday afternoon the Australian shares were trading lower, in line with Wall Street which closed lower in overnight trade. The market extended losses for the second straight session, led by losses in bank, health care and energy stocks...

The ASX is pulling off a near perfect imitation of a roller coaster, pulling back 0.6% following yesterday’s 1.4% gain and Monday’s 1.8% fall, or an overall drop of 1% for the week. The ASX 200 closed at 7,299 while the ASX Emerging Compani...

The Althea Group Holdings Ltd (ASX: AGH) share price has been a positive performer on Wednesday. In early trade, the cannabis company’s shares are up 4.5% to 33.5 cents. Why is the Althea share price on a high today? Investors have been bu...

Wall Street rebounds as Nasdaq resets record high All three major US benchmarks rose overnight, as investors adjusted to the Fed’s rate outlook. The Dow Jones rose by 0.20%, S&P 500 by 0.51%, and tech heavy Nasdaq by 0.79%. Nasdaq close...

ShareCafeAlthea Group (ASX: AGH) – Hidden Gems Webinar Presenter – Robert Meissner – Chief Financial Officer & Company Secretary – Althea is an Australian licensed producer, supplier and exporter of pharmaceutical-grade medicinal canna...

ShareCafeHidden Gems Webinar Recap – Fresh Leaf Analytics, LGP, CAN, AGH & EMD Catch up on the full webinar with presentations from Fresh Leaf Analytics, Little Green Pharma (ASX: LGP), Cann Group (ASX: CAN) , Althea Group (ASX: AGH),...

Small caps have declined for the fourth time in the past five days — but still finished April with their strongest performance in six months. The Small Ordinaries index gained 4.83 per cent in April despite declining 0.96 per cent this week...

Summary Health House International has signed a non-exclusive distribution agreement with Dragonfly Biosciences. The agreement with Dragonfly would strengthen Health House’s product portfolio within Australia. The distribution agreeme...

Source: photolona, Shutterstock Summary Australian Primary Hemp has signed another retail distribution agreement with Coles Group Limited. Cannabis player Little Green Pharma has entered into a non-exclusive distribution agreement wit...

Source: Yarygin, Shutterstock Summary The Australian cannabis market is flourishing with growing patient numbers and better product selection. Medicinal cannabis player Bod Australia has won a new PO for CBD products for the US cannab...

The S&P/ASX 200 Index (ASX: JXO) is having a pretty decent day today. A the time of writing, the ASX 200 is up a healthy pre-Easter 0.21%. But one group that is doing a quarter-ounce better are ASX cannabis shares. Take Creso Pharma Lt...